Top compounds associated with response to TMEM198


Feature Type Standardized
Nominal ANOVA
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.18 1e-05
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.16 2e-05
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.16 2e-05
mRNA CHIR-99021 GDSC1000 pan-cancer AAC -0.14 2e-05
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.16 2e-05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.14 3e-05
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.14 3e-05
Download CSV